Contact us now to get immediate help: 1-855-350-3330
The processes that initiate and maintain alcoholism are regulated by interactions among nerve cells (i.e., neurons) in the brain. These mechanisms interact with emotional, cognitive, and social factors to determine an individual's response to alcohol consumption. Imaging techniques1 allow scientists to study the link between brain and behavior with minimal risk to the patient. Using imaging, scientists can watch the brain in action as a person performs intellectual tasks, reacts to the environment, or experiences emotions. Data obtained before, during, and after a person has consumed alcohol can be compared and analyzed. Imaging offers the promise of integrating biomedical, psychosocial, and behavioral aspects of alcoholism, leading to improved prevention and treatment. This Alcohol Alert illustrates some current and potential applications of imaging to alcoholism research.
Imaging reveals shrinkage to be more extensive in the folded outer layer (i.e., cortex) of the frontal lobe (2), which is believed to be the seat of higher intellectual functions. In men, vulnerability to frontal lobe shrinkage increases with age (2-4). Current studies will determine if the same effect occurs in women. Repeated imaging of a group of alcoholics who continued drinking over a 5-year period showed progressive brain shrinkage that significantly exceeded normal age-related shrinkage (5). The rate of frontal cortex shrinkage in this study correlated approximately with the amount of alcohol consumed (5).
Shrinkage also occurs in deeper brain regions, including brain structures associated with memory (6-8), as well as in the cerebellum, which helps regulate coordination and balance (9). Limited research suggests that women may be more susceptible than men to alcohol-related brain shrinkage (10,11).
The detection of structural brain damage is complemented by results of functional imaging techniques, such as positron emission tomography (PET) and single photon emission computed tomography (SPECT). By measuring local changes in blood flow and energy metabolism, PET and SPECT can help identify brain regions involved in specific sensory, motor, or cognitive functions. Such studies consistently reveal decreased blood flow and metabolic rates in certain brain regions of heavy drinkers compared with those of nonalcoholics (12,13), even in the absence of measurable shrinkage (14). Structural and functional defects revealed by magnetic resonance spectroscopy (MRS) and PET may reflect a decrease in the number (15) or size (16,17) of neurons or a reduction in the density of communication sites between adjacent neurons (16,17).
Relating Structure and Function to Behavior
A key goal of imaging in alcoholism research is to detect changes in specific brain regions that can be correlated with alcohol-related behaviors. Imaging of the cerebellum has linked both shrinkage (9,18) and decreased blood flow (19) to impaired balance and gait. Such impairment may cause falls among older alcoholics, leading to head injury that may exacerbate brain dysfunction. Studies of cognitive performance, however, have found no consistent relationship between shrinkage of the frontal cortex and impairment of short-term memory and problem-solving (1,20), functions typically disrupted by frontal lobe damage. Conversely, some studies have found an approximate correlation between shrinkage of memory-related brain structures (e.g., mammillary bodies) and the degree of memory impairment (7). Functional imaging studies show that frontal lobe blood flow (21) and metabolism (12) may decrease in alcoholics before significant shrinkage or major cognitive problems become detectable (13,21).
Cognitive functions and motor coordination may improve at least partially within 3 to 4 weeks of abstinence (20) accompanied by at least partial reversal of brain shrinkage (22,23) and some recovery of metabolic functions in the frontal lobes (24) and cerebellum (17,25). Frontal lobe blood flow continues to increase with abstinence, returning to approximately normal levels within 4 years (26). Relapse to drinking leads to resumption of shrinkage (23), continued declines in metabolism and cognitive function (24), and evidence of neuronal cell damage (25).
Functional imaging reveals that alcoholics have diminished metabolic activity in several frontal brain regions early and late in withdrawal (29,30). In nonalcoholics, benzodiazepine sedatives, some of which are commonly used to treat alcohol withdrawal, produce a temporary alcohol-like impairment of coordination and cognition accompanied by an overall decrease in the brain's metabolic rate. In alcoholics, some frontal brain regions exhibit a smaller metabolic change following benzodiazepine administration than is seen in nonalcoholics. These results may indicate a diminished capacity for dampening excessive neuronal activity, possibly weakening a person's ability to inhibit behavior (30). Among nonalcoholic social drinkers, the effects of benzodiazepines on specific brain regions as assessed by PET (31) and functional MRI (32) differ between persons with and without a family history of alcoholism. Therefore, an abnormal reaction to benzodiazepines may represent a preexisting risk factor for alcoholism rather than a consequence of long-term alcohol consumption.
A promising application of functional imaging is in the study of cognitive and emotional processes involved in addiction, craving, and relapse. For example, preliminary studies have correlated craving for cocaine with increased metabolism in a neuronal network that integrates emotional and cognitive aspects of memory (33). Similar mechanisms implicated in craving for alcohol may help account for individual differences in vulnerability to alcoholism (34).
Withdrawal. Up to 15 percent of alcoholics experience seizures during withdrawal, and the likelihood of having such seizures, as well as their severity, increases with the number of past withdrawal episodes. In a structural imaging study of alcoholics who had undergone seizures, Sullivan and colleagues (38) found shrinkage on both sides of the brain behind the frontal lobes. It is not known whether seizures cause the shrinkage or result, in part, from preexisting damage to the area.
Investigators have used PET and SPECT to locate and quantify sites on neuronal surfaces where neurotransmitters implicated in the development of alcoholism interact with the neuron. Results of such research has implicated impaired serotonin function in the severe depression that often accompanies withdrawal (39). Functional imaging is also being used to help evaluate the effects of naloxone on withdrawal-induced craving (40). This medication is chemically related to the anticraving medication naltrexone (ReVia(TM)).
Psychosocial Therapies. Higgins (41) describes the concept of neurobehavioral treatment, which emphasizes learning-based approaches to relapse prevention while paying special attention to the neurobiologic changes that accompany abstinence. For example, a common treatment strategy involves the development of skills for recognizing and coping with environmental influences or emotional states that may induce craving and trigger drinking. This approach requires the ability to monitor and evaluate one's behavior and learn from failed efforts (41). Researchers are using functional imaging to investigate the basis for impairment of these cognitive functions (42).
Appendix: Imaging Techniques
Structural imaging depicts a three-dimensional "slice" of the brain, showing more detail than a conventional X ray. CT is a refinement of x-ray technology, whereas MRI interprets signals emitted by the brain in the presence of a strong magnetic field (43). These techniques are commonly used to help diagnose certain medical conditions (e.g., tumors) as well as in research.
Functional imaging techniques in common use include PET, SPECT, and modifications of magnetic resonance technology (14,43). PET and SPECT provide computer-generated, color-coded, three-dimensional images of the distribution within the brain of radioactive substances injected into the bloodstream. These images can be used to detect changes in blood flow in specific brain regions or to determine the locations of various neurotransmitters or receptors. Functional MRI can locate and assess levels of brain activation associated with motor, sensory, or cognitive processes that may be impaired by alcohol over time at intervals as short as a few seconds (44). MRS can detect specific molecules, including alcohol itself (45), and can detect metabolic changes underlying deterioration of neuronal structural integrity (43).
Imaging and Alcoholism: A Window on the Brain-A Commentary by NIAAA Director Enoch Gordis, M.D.
Imaging technology has helped alcohol researchers to study how alcohol damages internal organs, such as the brain and the liver. More recent advances in imaging techniques are allowing investigators to also study alcohol dependence itself. Scientists are beginning to measure alcohol's effects on mood, emotional states, craving, and cognition while simultaneously assessing metabolic, physiologic, and neurochemical function in the brain. These innovations in imaging technology will help not only the alcohol field, but also all fields of medicine where biology and behavior are so closely linked.
(1) Rosenbloom, M.J.; Pfefferbaum, A.; and Sullivan, E.V. Structural brain alterations associated with alcoholism. Alcohol Health Res World 19(4):266-272, 1995. (2) Pfefferbaum, A.; Sullivan, E.V.; Mathalon, D.H.; et al. Frontal lobe volume loss observed with magnetic resonance imaging in older chronic alcoholics. Alcohol Clin Exp Res 21(3):521-529, 1997. (3) Pfefferbaum, A.; Lim, K.O.; Zipursky, R.B.; et al. Brain gray and white matter volume loss accelerates with aging in chronic alcoholics: A quantitative MRI study. Alcohol Clin Exp Res 16(6):1078-1089, 1992. (4) Pfefferbaum, A.; Sullivan, E.V.; Rosenbloom, M.J.; et al. Increase in brain cerebrospinal fluid volume is greater in older than in younger alcoholic patients: A replication study and CT/MRI comparison. Psychiatry Res 50(4):257-274, 1993. (5) Pfefferbaum, A.; Sullivan, E.V.; Rosenbloom, M.J.; et al. A controlled study of cortical gray matter and ventricular changes in alcoholic men over a 5-year interval. Arch Gen Psychiatry 55(10):905-912, 1998. (6) Sullivan, E.V.; Marsh, L.; Mathalon, D.H.; et al. Anterior hippocampal volume deficits in nonamnesic, aging chronic alcoholics. Alcohol Clin Exp Res 19(1):110-122, 1995a. (7) Sullivan, E.V.; Lane, B.; Deshmukh, A.; et al. In vivo mammillary body volume deficits in amnesic and nonamnesic alcoholics. Alcohol Clin Exp Res 23(10):1629-1636, 1999. (8) Agartz, I.; Momenan, R.; Rawlings, R.R.; et al. Hippocampal volume in patients with alcohol dependence. Arch Gen Psychiatry 56(4):356-363, 1999. (9) Sullivan, E.V.; Rosenbloom, M.J.; Deshmukh, A.; et al. Alcohol and the cerebellum: Effects on balance, motor coordination, and cognition. Alcohol Health Res World 19(2):138-141, 1995b. (10) Hommer, D.; Momenan, R.; Rawlings, R.; et al. Decreased corpus callosum size among alcoholic women. Arch Neurol 53(4):359-363, 1996a. (11) Hommer, D.; Momenan, R.; Ragan, P.; et al. Changes in CSF, ventricular, gray and white matter volumes in female alcoholics measured by automated segmentation of MRI images. Alcohol Clin Exp Res 20(2 Suppl.):33A, 1996b. (12) Volkow, N.D.; Hitzemann, R.; Wang, G.-J.; et al. Decreased brain metabolism in neurologically intact healthy alcoholics. Am J Psychiatry 149(8):1016-1022, 1992. (13) Wang, G.-J.; Volkow, N.D.; Roque, C.T.; et al. Functional importance of ventricular enlargement and cortical atrophy in healthy subjects and alcoholics as assessed with PET, MR imaging, and neuropsychologic testing. Radiology 186(1):59-65, 1993. (14) Fowler, J.S., and Volkow, N.D. PET imaging studies in drug abuse. Clin Toxicol 36(3):163-174, 1998. (15) Mann, K. Alcohol and the brain: Neuropathology and imaging studies. In: Peters, T.J. Alcohol Misuse: An European Perspective. Amsterdam, The Netherlands: Harwood Academic Publishers, 1996. pp. 99-121. (16) Jagannathan, N.R.; Desai, N.G.; and Raghunathan, P. Brain metabolite changes in alcoholism: An in vivo proton magnetic resonance spectroscopy (MRS) study. Magn Reson Imaging 14(5):553-557, 1996. (17) Seitz, D.; Widmann, U.; Seeger, U.; et al. Localized protein magnetic resonance spectroscopy of the cerebellum in detoxifying alcoholics. Alcohol Clin Exp Res 23(1)158-163, 1999. (18) Sullivan, E.V.; Deshmukh, A.; Desmond, J.E.; et al. Cerebellar volume deficits and neuropsychological functions in alcoholics. Alcohol Clin Exp Res 22(3 Suppl.): 63A, 1998. (19) Ingvar, M.; Ghatan, P.H.; Wirsén-Meurling, A.; et al. Alcohol activates the cerebral reward system in man. J Stud Alcohol 59(3):258-269, 1998. (20) Oscar-Berman, M.; Shagrin, B.; Evert, D.L.; et al. Impairments of brain and behavior: The neurological effects of alcohol. Alcohol Health Res World 21(1):65-75, 1997. (21) Nicolás, J.M.; Catafau, A.M.; Estruch, R.; et al. Regional cerebral blood flow-SPECT in chronic alcoholism: Relation to neuropsychological testing. J Nuc Med 34(9):1452-1459, 1993. (22) Shear, P.K.; Jernigan, T.L.; and Butters, N. Volumetric magnetic resonance imaging quantification of longitudinal brain changes in abstinent alcoholics. Alcohol Clin Exp Res 18(1):172-176, 1994. (23) Pfefferbaum, A.; Sullivan, E.V.; Mathalon, D.H.; et al. Longitudinal changes in magnetic resonance imaging brain volumes in abstinent and relapsed alcoholics. Alcohol Clin Exp Res 19(5):1177-1191, 1995. (24) Johnson-Greene, D.; Adams, K.M.; Gilman, S.; et al. Effects of abstinence and relapse upon neuropsychological function and cerebral glucose metabolism in severe chronic alcoholism. J Clin Exp Neuropsychol 19(3):378-385, 1997. (25) Martin, P.R.; Gibbs, S.J.; Nimmerrichter, A.A.; et al. Brain proton magnetic resonance spectroscopy studies in recently abstinent alcoholics. Alcohol Clin Exp Res 19(4):1078-1082, 1995. (26) Gansler, D.A.; Harris, G.J.; Oscar-Berman, M.; et al. Hypoperfusion of inferior frontal brain regions in abstinent alcoholics: A pilot SPECT study. J Stud Alcohol 61(1):32-37, 2000. (27) Modell, J.G., and Mountz, J.M. Focal cerebral blood flow change during craving for alcohol measured by SPECT. J Neuropsychiatry 7(1):15-22, 1995. (28) Hommer, D.; Andreasen, P.; Rio, D.; et al. Effects of m-chlorphenylpiperazine on regional brain glucose utilization: A positron emission tomographic comparison of alcoholic and control subjects. J Neurosci 17(8):2796-2806, 1997. (29) Volkow, N.D.; Wang, G.-J.; Hitzemann, R.; et al. Decreased cerebral response to inhibitory neurotransmission in alcoholics. Am J Psychiatry 150(3):417-422, 1993. (30) Volkow, N.D.; Wang, G.-J.; Overall, J.E.; et al. Regional brain metabolic response to lorazepam in alcoholics during early and late alcohol detoxification. Alcohol Clin Exp Res 21(7):1278-1284, 1997. (31) Volkow, N.D.; Wang, G.-J.; Begleiter, H.; et al. Regional brain metabolic response to lorazepam in subjects at risk for alcoholism. Alcohol Clin Exp Res 19(2):510-516, 1995. (32) Streeter, C.C.; Ciraulo, D.A.; Harris, G.J.; et al. Functional magnetic resonance imaging of alprazolam-induced changes in humans with familial alcoholism. Psychiatry Res 82:69-82, 1998. (33) Grant, S.; London, E.D.; Newlin, D.B.; et al. Activation of memory circuits during cue-elicited cocaine craving. Proc Nat Acad Sci USA 93(21):12040-12045, 1996. (34) Verheul, R.; Van den Brink, W.; and Geerlings, P. A three-pathway psychobiological model of craving for alcohol. Alcohol Alcohol 34(2):197-222, 1999. (35) Bannister, R. Brain and Bannister's Clinical Neurology. 7th ed. New York: Oxford University Press, 1992. (36) Lim, K.O.; Hedehus, M.; Moseley, M.; et al. Compromised white matter tract integrity in schizophrenia inferred from diffusion tensor imaging. Arch Gen Psychiatry 56(4):367-374, 1999. (37) Sheedy, D.; Lara, A.; Garrick, T.; et al. Size of mammillary bodies in health and disease: Useful measurements in neuroradiological diagnosis of Wernicke's encephalopathy. Alcohol Clin Exp Res 23(10):1624-1628, 1999. (38) Sullivan, E.V.; Marsh, L.; Mathalon, D.H.; et al. Relationship between alcohol withdrawal seizures and temporal lobe white matter volume deficits. Alcohol Clin Exp Res 20(2):348-354, 1996. (39) Heinz, A.; Ragan, P.; Jones, D.W.; et al. Reduced central serotonin transporters in alcoholism. Am J Psychiatry 155(11):1544-1549, 1998. (40) Ilgin, N.; Eldeiry, S.; Mandold, D.; et al. Measurement of brain mu opioid receptor binding in alcohol dependence by PET. J Nuc Med 38 (Suppl. 5):34P, 1997. (41) Higgins, S.T. Applying learning and conditioning theory to the treatment of alcohol and cocaine abuse. In: Johnson, B.A., and Roache, J.D., eds. Drug Addiction and Its Treatment: Nexus of Neuroscience and Behavior. Philadelphia: Lippincott-Raven, 1997. pp. 367-385. (42) Weingartner, H.J.; Andreason, P.J.; Hommer, D.W.; et al. Monitoring the source of memory in detoxified alcoholics. Biol Psychiatry 40(1):43-53,1996. (43) Pfefferbaum, A., and Rosenbloom, M.J. Brain-imaging tools for the study of alcoholism. Alcohol Health Res World 14(3):219-231, 1990. (44) Levin, J.M.; Ross, M.H.; Mendelson, J.H.; et al. Reduction in BOLD fMRI response to primary visual stimulation following alcohol ingestion. Psychiatry Res 82(3):135-146, 1998. (45) Spielman, D.M.; Glover, G.H.; Macovski, A.; et al. Magnetic resonance spectroscopic imaging of ethanol in the human brain: A feasibility study. Alcohol Clin Exp Res 17(5):1072-1077, 1993.
Find Top Treatment Facilities Near You
Speak with a Certified Treatment Assesment Counselor who can go over all your treatment options and help you find the right treatment program that fits your needs.
Discuss Treatment Options!
Our Counselors are available 24 hours a day, 7 days a week to discuss your treatment needs and help you find the right treatment solution.
© Copyright 1998 - 2018 All Rights Reserved. Content is protected under copyright laws, do not use content without written permission.